In contrast, a number of meta-analyses indicate no marked associations of GSTM1 gene polymorphism with hepatocellular carcinoma [40], gastric cancer [41], esophageal cancer [42] and prostate cancer [43]. This evidence concerns the gene GSTM1 and gastric cancer.